BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $332.16 million. The enterprise value is $257.94 million.
Important Dates
The next confirmed earnings date is Tuesday, November 11, 2025, before market open.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 37.79 million shares outstanding. The number of shares has increased by 12.72% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 37.79M |
| Shares Change (YoY) | +12.72% |
| Shares Change (QoQ) | -26.76% |
| Owned by Insiders (%) | 19.50% |
| Owned by Institutions (%) | 21.02% |
| Float | 23.28M |
Valuation Ratios
The trailing PE ratio is 62.16.
| PE Ratio | 62.16 |
| Forward PE | n/a |
| PS Ratio | 7.21 |
| Forward PS | 1.68 |
| PB Ratio | 4.88 |
| P/TBV Ratio | 4.88 |
| P/FCF Ratio | 17.73 |
| P/OCF Ratio | 14.34 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 77.67, with an EV/FCF ratio of 13.77.
| EV / Earnings | 48.27 |
| EV / Sales | 5.60 |
| EV / EBITDA | 77.67 |
| EV / EBIT | 138.23 |
| EV / FCF | 13.77 |
Financial Position
The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.49 |
| Quick Ratio | 3.21 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.61 |
| Debt / FCF | 0.33 |
| Interest Coverage | 1.13 |
Financial Efficiency
Return on equity (ROE) is 9.62% and return on invested capital (ROIC) is 1.99%.
| Return on Equity (ROE) | 9.62% |
| Return on Assets (ROA) | 1.32% |
| Return on Invested Capital (ROIC) | 1.99% |
| Return on Capital Employed (ROCE) | 2.17% |
| Revenue Per Employee | $384,033 |
| Profits Per Employee | $44,533 |
| Employee Count | 120 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.95 |
Taxes
In the past 12 months, BrainsWay has paid $490,000 in taxes.
| Income Tax | 490,000 |
| Effective Tax Rate | 8.40% |
Stock Price Statistics
The stock price has increased by +69.35% in the last 52 weeks. The beta is 0.25, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +69.35% |
| 50-Day Moving Average | 15.72 |
| 200-Day Moving Average | 11.93 |
| Relative Strength Index (RSI) | 62.80 |
| Average Volume (20 Days) | 60,340 |
Short Selling Information
| Short Interest | 150,209 |
| Short Previous Month | 170,894 |
| Short % of Shares Out | 1.27% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.40 |
Income Statement
In the last 12 months, BrainsWay had revenue of $46.08 million and earned $5.34 million in profits. Earnings per share was $0.11.
| Revenue | 46.08M |
| Gross Profit | 34.34M |
| Operating Income | 1.87M |
| Pretax Income | 5.83M |
| Net Income | 5.34M |
| EBITDA | 3.32M |
| EBIT | 1.87M |
| Earnings Per Share (EPS) | $0.11 |
Full Income StatementBalance Sheet
The company has $78.00 million in cash and $6.13 million in debt, giving a net cash position of $71.87 million or $1.90 per share.
| Cash & Cash Equivalents | 78.00M |
| Total Debt | 6.13M |
| Net Cash | 71.87M |
| Net Cash Per Share | $1.90 |
| Equity (Book Value) | 68.13M |
| Book Value Per Share | 1.80 |
| Working Capital | 63.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $23.17 million and capital expenditures -$4.43 million, giving a free cash flow of $18.73 million.
| Operating Cash Flow | 23.17M |
| Capital Expenditures | -4.43M |
| Free Cash Flow | 18.73M |
| FCF Per Share | $0.50 |
Full Cash Flow StatementMargins
Gross margin is 74.52%, with operating and profit margins of 4.05% and 11.60%.
| Gross Margin | 74.52% |
| Operating Margin | 4.05% |
| Pretax Margin | 12.66% |
| Profit Margin | 11.60% |
| EBITDA Margin | 7.21% |
| EBIT Margin | 4.05% |
| FCF Margin | 40.65% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.72% |
| Shareholder Yield | -12.72% |
| Earnings Yield | 1.61% |
| FCF Yield | 5.64% |
Analyst Forecast
The average price target for BrainsWay is $18.00, which is 6.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.00 |
| Price Target Difference | 6.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BrainsWay has an Altman Z-Score of 2.29 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.29 |
| Piotroski F-Score | 4 |
